Related Experiment Video
Updated: May 10, 2026
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Molecular landscape of prostate cancer bone metastasis
Santanu Maji1, Amit Kumar1, Luni Emdad2
1Department of Human and Molecular Genetics, Virginia Commonwealth University, School of Medicine, Richmond, VA, United States.
Abstract:
Prostate cancer (PC) has a high propensity to develop bone metastases, causing severe pain and pathological fractures that profoundly impact a patients' normal functions. Current clinical intervention is mainly palliative focused on pain management, and tumor progression is refractory to standard therapeutic regimens. This limited treatment efficacy is at least partially due to a lack of comprehensive understanding of the molecular landscape of the disease pathology, along with the intensive overlapping of physiological and pathological molecular signaling. The niche is overwhelmed with diverse cell types with inter- and intra-heterogeneity, along with growth factor-enriched cells that are supportive of invading cell proliferation, providing an additional layer of complexity. This review seeks to provide molecular insights into mechanisms underlying PC bone metastasis development and progression.
Insights
Prostate cancer bone metastasis causes pain and fractures. Understanding its complex molecular mechanisms is crucial for developing effective treatments beyond palliative care.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metastasis
Background:
- Prostate cancer frequently metastasizes to bone, leading to significant morbidity.
- Current treatments for bone metastases are largely palliative and tumor progression is often refractory.
- Limited understanding of the molecular landscape and signaling pathways hinders effective therapeutic development.
Purpose of the Study:
- To review and elucidate the molecular mechanisms driving prostate cancer bone metastasis.
- To highlight the complexities of the tumor microenvironment in bone metastasis.
- To provide insights for future therapeutic strategies.
Main Methods:
- Literature review of preclinical and clinical studies.
- Analysis of molecular signaling pathways involved in prostate cancer bone metastasis.
- Discussion of cellular heterogeneity and the tumor niche.
Main Results:
- Prostate cancer bone metastasis involves intricate molecular signaling and cellular interactions.
- The bone microenvironment presents unique challenges and supports tumor growth.
- Heterogeneity within tumor cells and the niche contributes to treatment resistance.
Conclusions:
- A deeper molecular understanding is essential for improving treatment efficacy.
- Targeting specific pathways and the tumor microenvironment may offer new therapeutic avenues.
- Further research into the molecular basis of prostate cancer bone metastasis is warranted.
Related Concept Videos
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...